VIRX Shares Outstanding History — Viracta Therapeutics Share Count Over Time

As of 11/11/2024 Viracta Therapeutics has 39.74 million VIRX shares outstanding. Investors often track the VIRX shares outstanding history to compare shareholder return trends against the change in share count over time.

This page shows VIRX share count trends over time, with 16 historical shares outstanding datapoints presented, dating back to 2/25/2021.

Quick links: Shares Outstanding History Table  |  Shares Outstanding History Chart  |  About Viracta Therapeutics
VIRX Shares Outstanding History



Below is a table of the VIRX shares outstanding history going back to 2/25/2021:

Date VIRX Shares Outstanding
2/25/202137.00M
5/7/202137.04M
8/2/202137.23M
11/3/202137.31M
3/4/202237.49M
5/2/202237.49M
8/1/202237.56M
11/1/202238.20M
3/6/202338.41M
5/1/202338.41M
8/4/202338.58M
11/6/202338.62M
3/4/202439.27M
5/6/202439.27M
8/5/202439.42M
11/11/202439.74M

Also see: VIRX Market Cap History
VIRX YTD Return
VIRX Historical Shares Outstanding:
+1.95% CAGR
VIRX Historical Shares Outstanding: +1.95% CAGR

Mouse over chart for data details
2/25/2021 ...11/11/2024
Viracta Therapeutics, Inc. is a clinical-stage precision oncology company focused on treating and preventing virus-associated cancers. Its lead product, Nana-val, combines nanatinostat and valganciclovir. Nana-val is being tested in several clinical trials, including a Phase II trial for relapsed or refractory Epstein-Barr virus-positive (EBV+) lymphoma (NAVAL-1) and a Phase Ib/II trial for recurrent or metastatic EBV+ nasopharyngeal carcinoma and other advanced EBV+ solid tumors. Viracta is also exploring its Kick and Kill approach for other virus-related cancers. We show 16 historical shares outstanding datapoints in our coverage of VIRX's shares outstanding history.

Understanding the changing numbers of VIRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VIRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VIRX by allowing them to research VIRX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree VIRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance
Viracta Therapeutics (VIRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

VIVE Shares Outstanding History
VIVK Shares Outstanding History
VIVO Shares Outstanding History
VIVS Shares Outstanding History
VKTX Shares Outstanding History
VLON Shares Outstanding History
VLRX Shares Outstanding History
VNDA Shares Outstanding History
VOR Shares Outstanding History
VRAY Shares Outstanding History
More Healthcare companies »
 

VIRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.